CML . Reminiscences and dreams
2011-09-22 - English

A novel AHI-1-BCR-ABL-JAK2 interaction complex mediates cellular resistance to tyrosine kinase inhibitors in CML stem/progenitor cells
2011-09-22 - English
available!

Evaluation of the efficacy and mechanism of action of the JAK2 inhibitor INCB18424 in primary CML stem/progenitor cells
2011-09-22 - English
available!

The BELA trial: 18-month update on safety and clinical activity in patients with chronic phase CML treated with bosutirub (SKI-606) or imatinib
2011-09-22 - English
available!

How do we define the \'best\' front-line therapy for CML and can we afford it?
2011-09-22 - English
available!

Correlation of hOCT1 genetic polymorphisms with the clinical outcome Athina Giannoudis (Liverpool) of CML patients treated with imatinib
2011-09-24 - English
available!

Switching to nilotinib vs imatinib dose escalation for patients with suboptimal treatment response to imatinib: 24 month update of the TIDEL-II trial
2011-09-24 - English
available!

All CML patients should start treatment with 2G-TKI: yes
2011-09-25 - English
to be announced!

All CML patients should start treatment with 2G-TKI: no
2011-09-25 - English
available!

Stopping TKI can now be recommended in selected partients: no
2011-09-25 - English